FindTrial
Sign In

A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of insulin peglispro (LY2605541) in Healthy Male Japanese Subjects

A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of insulin peglispro (LY2605541) in Healthy Male Japanese Subjects

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222319
Enrollment
Unknown
Registered
2013-12-09
Start date
2013-12-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Interventions

investigational material(s) Generic name etc : insulin peglispro INN of investigational material : Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosa

Sponsors

Eli Lilly Japan K.K.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Participants are overtly healthy male Japanese. Participants have Body Mass Index (BMI) between 18.5 and 25.0 kilogram per square meter (kg/m^2), inclusive.

Exclusion criteria

Exclusion criteria: Participants have known allergies to insulin peglispro, related compounds. Participants have a fasting venous blood glucose >108 milligram per deciliter (mg/dL) (>6 millimole per liter [mmol/L]).

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026